News

• Dr. Henig adds leadership and development expertise in pulmonary disease, inhaled therapies, and orphan disease to the executive management team

•...

Read more

• Top-tier drug development executive joins Board of Directors

• Important reinforcement for development of lead program in Bronchiolitis Obliterans...

Read more

Breath Therapeutics BV announced today the appointment of Melissa Yeager as Chief Regulatory Officer. Ms Yeager will join the executive management and...

Read more

Breath Therapeutics BV, a PARI Pharma GmbH spin-out developing advanced drug-aerosol therapeutics in pulmonary orphan indications, today announced the...

Read more